Showing 1 - 6 results of 6 for search 'Pierangela Sepe', query time: 0.03s Refine Results
  1. 1
    Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer

    Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer by Alessandra Raimondi, Pierangela Sepe, Emma Zattarin, Alessia Mennitto, Marco Stellato, Melanie Claps, Valentina Guadalupi, Elena Verzoni, Filippo de Braud, Filippo de Braud, Giuseppe Procopio

    Published 2020-08-01
    Get full text
    Article
  2. 2
    Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators

    Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators by Marco Stellato, Giuseppe Procopio, Ugo De Giorgi, Marco Maruzzo, Davide Bimbatti, Alessia Mennitto, Andrea Sbrana, Giandomenico Roviello, Chiara Casadei, Pierangela Sepe, Sandro Pignata, Daniele Santini

    Published 2021-08-01
    Get full text
    Article
  3. 3
    Outpatient palliative care referral system (PCRS) for patients with advanced cancer: an impact evaluation protocol

    Outpatient palliative care referral system (PCRS) for patients with advanced cancer: an impact evaluation protocol by Filippo de Braud, Alessandra Raimondi, Salvatore Provenzano, Marta Brambilla, Cinzia Brunelli, Monica Niger, Ernesto Zecca, Paola Bracchi, Silvia Lo Dico, Mariangela Caputo, Alessandra Pigni, Viviana Fusetti, Antonino Tallarita, Cristiana Bergamini, Pierangela Sepe, Sara Alfieri, Gabriele Tinè, Augusto Tommaso Caraceni

    Published 2022-10-01
    Get full text
    Article
  4. 4
    Antitumor activity and efficacy of shorter longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II–III HER2-negative breast cancer: a 10-year, retrospective analysis

    Antitumor activity and efficacy of shorter longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II–III HER2-negative breast cancer: a 10-year, retrospective a... by Riccardo Lobefaro, Emma Zattarin, Federico Nichetti, Michele Prisciandaro, Francesca Ligorio, Marta Brambilla, Pierangela Sepe, Francesca Corti, Giorgia Peverelli, Arianna Ottini, Teresa Beninato, Laura Mazzeo, Carmen G. Rea, Gabriella Mariani, Filippo de Braud, Giulia V. Bianchi, Claudio Vernieri, Giuseppe Capri

    Published 2020-12-01
    Get full text
    Article
  5. 5
    Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors

    Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors by Giandomenico Roviello, Martina Catalano, Ugo De Giorgi, Marco Maruzzo, Sebastiano Buti, Sebastiano Buti, Elisabetta Gambale, Giuseppe Procopio, Carlotta Ottanelli, Enrico Caliman, Enrico Caliman, Luca Isella, Pierangela Sepe, Nicole Brighi, Matteo Santoni, Luca Galli, Raffaele Conca, Laura Doni, Lorenzo Antonuzzo, Lorenzo Antonuzzo

    Published 2022-08-01
    Get full text
    Article
  6. 6
    A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study)

    A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral diseas... by Pierangela Sepe, Giuseppe Procopio, Chiara Carlotta Pircher, Umberto Basso, Orazio Caffo, Vera Cappelletti, Melanie Claps, Ugo De Giorgi, Lucia Fratino, Valentina Guadalupi, Patrizia Miodini, Cinzia De Marco, Bruno Perrucci, Alessia Mennitto, Daniele Santini, Francesco Spina, Marco Stellato, Filippo de Braud, Elena Verzoni

    Published 2024-01-01
    Get full text
    Article

Search Tools: